Lista de obras - Martha Sedegah - Dominio Público Uruguay

A Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus Macaques

artículo científico publicado en 2007

A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates

artículo científico publicado en 2013

A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230.

artículo científico publicado en 2003

A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner

artículo científico publicado en 2004

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

artículo científico publicado en 2015

Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults

artículo científico publicado en 2011

Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component

artículo científico publicado en 2011

Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation

artículo científico publicado en 2014

Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro

artículo científico publicado en 2017

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

artículo científico publicado en 2012

Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein

artículo científico publicado en 2015

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming

artículo científico publicado en 2015

Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

artículo científico publicado en 2016

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity

artículo científico publicado en 2013

Decrease in circulating CD25(hi)Foxp3(+) regulatory T cells following vaccination with the candidate malaria vaccine RTS,S.

artículo científico publicado en 2016

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

artículo científico publicado en 2010

Development of replication-deficient adenovirus malaria vaccines

artículo científico publicado en 2016

Development of whole sporozoite malaria vaccines

artículo científico publicado en 2016

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development

artículo científico publicado en 2015

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vec

artículo científico publicado en 2013

Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines

artículo científico publicado en 2007

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

artículo científico publicado en 2002

Human adenovirus 5-vectoredPlasmodium falciparumNMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection ⬇️

artículo científico publicado el 4 de junio de 2013

Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein

artículo científico publicado en 2010

Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population

artículo científico publicado en 2020

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

artículo científico publicado en 2013

Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates

artículo científico publicado en 2011

Immunological responses of neonates and infants to DNA vaccines

artículo científico publicado en 2006

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria

artículo científico publicado en 2016

Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults

artículo científico publicado en 2015

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults

artículo científico publicado en 2011

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity

artículo científico publicado en 2016

New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model

artículo científico publicado en 2017

Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations

artículo científico publicado en 2002

Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity

artículo científico publicado en 2009

Profiling the Targets of Protective CD8+ T Cell Responses to Infection

artículo científico publicado en 2017

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

artículo científico publicado en 2017

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

artículo científico publicado en 2013

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

artículo científico publicado en 2002

Reduced production of RNA transcripts from individual DNA plasmids given in a multivalent DNA vaccine formula

artículo científico publicado en 2007

Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update

artículo científico publicado en 2007

Seroprevalence of antibodies against plasmodium falciparum sporozoite antigens as predictive disease transmission markers in an area of Ghana with seasonal malaria transmission

artículo científico publicado en 2016

Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes

artículo científico publicado en 2014

Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers

artículo científico publicado en 2003

T-cell responses against Malaria: Effect of parasite antigen diversity and relevance for vaccine development

artículo científico publicado en 2018

The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay

artículo científico publicado en 2015

Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

artículo científico publicado en 2016

Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses

artículo científico publicado en 2009

Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines

artículo científico publicado en 2005

Lista de obras de Martha Sedegah

A Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus Macaques

A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates

A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230.

A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults

Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component

Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation

Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming

Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity

Decrease in circulating CD25(hi)Foxp3(+) regulatory T cells following vaccination with the candidate malaria vaccine RTS,S.

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

Development of replication-deficient adenovirus malaria vaccines

Development of whole sporozoite malaria vaccines

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vec

Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

Human adenovirus 5-vectoredPlasmodium falciparumNMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection ⬇️

Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein

Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates

Immunological responses of neonates and infants to DNA vaccines

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria

Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity

New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model

Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations

Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity

Profiling the Targets of Protective CD8+ T Cell Responses to Infection

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Reduced production of RNA transcripts from individual DNA plasmids given in a multivalent DNA vaccine formula

Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update

Seroprevalence of antibodies against plasmodium falciparum sporozoite antigens as predictive disease transmission markers in an area of Ghana with seasonal malaria transmission

Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes

Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers

T-cell responses against Malaria: Effect of parasite antigen diversity and relevance for vaccine development

The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay

Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses

Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines